Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
System-based approaches as prognostic tools for glioblastoma.
Salvucci M, Zakaria Z, Carberry S, Tivnan A, Seifert V, Kögel D, Murphy BM, Prehn JHM. Salvucci M, et al. Among authors: tivnan a. BMC Cancer. 2019 Nov 12;19(1):1092. doi: 10.1186/s12885-019-6280-2. BMC Cancer. 2019. PMID: 31718568 Free PMC article. Review.
Advances in immunotherapy for the treatment of glioblastoma.
Tivnan A, Heilinger T, Lavelle EC, Prehn JH. Tivnan A, et al. J Neurooncol. 2017 Jan;131(1):1-9. doi: 10.1007/s11060-016-2299-2. Epub 2016 Oct 14. J Neurooncol. 2017. PMID: 27743144 Free PMC article. Review.
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.
Zakaria Z, Tivnan A, Flanagan L, Murray DW, Salvucci M, Stringer BW, Day BW, Boyd AW, Kögel D, Rehm M, O'Brien DF, Byrne AT, Prehn JH. Zakaria Z, et al. Among authors: tivnan a. Br J Cancer. 2016 Jan 19;114(2):188-98. doi: 10.1038/bjc.2015.420. Epub 2015 Dec 10. Br J Cancer. 2016. PMID: 26657652 Free PMC article.
Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.
Tivnan A, Heilinger T, Ramsey JM, O'Connor G, Pokorny JL, Sarkaria JN, Stringer BW, Day BW, Boyd AW, Kim EL, Lode HN, Cryan SA, Prehn JH. Tivnan A, et al. Oncotarget. 2017 Mar 7;8(10):16605-16620. doi: 10.18632/oncotarget.15073. Oncotarget. 2017. PMID: 28178667 Free PMC article.
MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma.
Bray I, Tivnan A, Bryan K, Foley NH, Watters KM, Tracey L, Davidoff AM, Stallings RL. Bray I, et al. Among authors: tivnan a. Cancer Lett. 2011 Apr 1;303(1):56-64. doi: 10.1016/j.canlet.2011.01.016. Cancer Lett. 2011. PMID: 21310526 Free PMC article.
18 results